Total Payments
$728,648
2024 Payments
$74,885
Companies
52
Transactions
1,584
Medicare Patients
7,519
Medicare Billing
$316,641
Payment Breakdown by Category
Other$644,776 (88.5%)
Travel$32,568 (4.5%)
Food & Beverage$30,071 (4.1%)
Consulting$20,629 (2.8%)
Education$395.32 (0.1%)
Research$150.00 (0.0%)
Gifts$59.40 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $626,115 | 334 | 85.9% |
| Travel and Lodging | $32,568 | 154 | 4.5% |
| Food and Beverage | $30,071 | 1,056 | 4.1% |
| Consulting Fee | $20,629 | 18 | 2.8% |
| Compensation for serving as faculty or as a speaker for a medical education program | $16,661 | 6 | 2.3% |
| Honoraria | $2,000 | 1 | 0.3% |
| Education | $395.32 | 10 | 0.1% |
| Unspecified | $150.00 | 4 | 0.0% |
| Gift | $59.40 | 1 | 0.0% |
Payments by Type
General
$728,498
1,580 transactions
Research
$150.00
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $356,525 | 395 | $0 (2024) |
| Lilly USA, LLC | $163,873 | 340 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $89,953 | 127 | $0 (2024) |
| Dexcom, Inc. | $33,133 | 56 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $17,421 | 60 | $0 (2024) |
| Abbott Laboratories | $16,757 | 60 | $0 (2024) |
| Mannkind Corporation | $16,694 | 88 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $7,621 | 28 | $0 (2018) |
| Tandem Diabetes Care, Inc. | $6,536 | 24 | $0 (2022) |
| Insulet Corporation | $5,531 | 50 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $74,885 | 187 | Lilly USA, LLC ($46,144) |
| 2023 | $80,964 | 210 | Lilly USA, LLC ($49,167) |
| 2022 | $102,502 | 252 | Lilly USA, LLC ($46,484) |
| 2021 | $92,735 | 140 | Novo Nordisk Inc ($64,855) |
| 2020 | $62,936 | 112 | Novo Nordisk Inc ($33,707) |
| 2019 | $99,793 | 235 | Novo Nordisk Inc ($60,773) |
| 2018 | $96,388 | 214 | Novo Nordisk Inc ($74,841) |
| 2017 | $118,444 | 234 | Novo Nordisk Inc ($69,675) |
All Payment Transactions
1,584 individual payment records from CMS Open Payments — Page 1 of 64
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Food and Beverage | In-kind items and services | $76.95 | General |
| Category: Endocrinology | ||||||
| 12/23/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,298.00 | General |
| Category: Endocrinology | ||||||
| 12/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Endocrinology | ||||||
| 12/18/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $22.86 | General |
| Category: Insulin Pump | ||||||
| 12/17/2024 | Neurocrine Biosciences, Inc. | CRENESSITY (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Neuropsychiatry | ||||||
| 12/17/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $0.60 | General |
| Category: Insulin Pump | ||||||
| 12/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Cardio-renal | ||||||
| 12/06/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 11/27/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Endocrinology | ||||||
| 11/19/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $22.69 | General |
| Category: Insulin Pump | ||||||
| 11/18/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Endocrinology | ||||||
| 11/18/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $0.41 | General |
| Category: Insulin Pump | ||||||
| 11/15/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 11/08/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Rare Disease | ||||||
| 10/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,550.00 | General |
| Category: Diabetes Care | ||||||
| 10/28/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $18.90 | General |
| Category: Insulin Pump | ||||||
| 10/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Cardio-renal | ||||||
| 10/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $122.10 | General |
| Category: Diabetes Care | ||||||
| 10/21/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/16/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/14/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $18.59 | General |
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: DIABETES | ||||||
| 10/07/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: DIABETES MEDICINE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| NN2211-3965 | Novo Nordisk Inc | $37.50 | 1 |
| THIS ACTIVE SURVEILLANCE PROGRAM WILL MONITOR FOR ANY SIGNAL INDICATING A POSSIBLE ASSOCIATION BETWEEN TREATMENT WITH LONG-ACTING GLP-1 RAS AND THE DEVELOPMENT OF MTC IN THE UNITED STATES POPULATION | Eli Lilly and Company | $37.50 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,883 | 2,652 | $371,854 | $78,691 |
| 2022 | 27 | 1,980 | 2,817 | $361,678 | $80,628 |
| 2021 | 27 | 1,828 | 2,848 | $339,750 | $82,362 |
| 2020 | 26 | 1,828 | 2,686 | $325,002 | $74,960 |
Total Patients
7,519
Total Services
11,003
Medicare Billing
$316,641
Procedure Codes
106
All Medicare Procedures & Services
106 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 179 | 233 | $52,946 | $18,590 | 35.1% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 202 | 210 | $85,847 | $14,918 | 17.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 260 | 407 | $35,107 | $6,583 | 18.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 92 | 103 | $14,567 | $5,582 | 38.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $17,756 | $5,051 | 28.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 28 | 28 | $13,141 | $4,149 | 31.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 296 | 493 | $13,908 | $4,071 | 29.3% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 50 | 73 | $14,691 | $2,953 | 20.1% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 76 | 76 | $32,341 | $2,607 | 8.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 171 | 251 | $13,769 | $2,582 | 18.8% |
| 82306 | Vitamin d-3 level | Office | 2023 | 65 | 74 | $13,066 | $2,147 | 16.4% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 19 | 19 | $16,299 | $1,684 | 10.3% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 106 | 158 | $11,173 | $1,397 | 12.5% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 44 | 63 | $5,434 | $1,045 | 19.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 22 | 22 | $3,120 | $962.84 | 30.9% |
| 86376 | Microsomal antibodies (autoantibody) measurement | Office | 2023 | 51 | 51 | $5,208 | $727.26 | 14.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 44 | 75 | $5,281 | $694.96 | 13.2% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 24 | 119 | $5,607 | $669.98 | 11.9% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 11 | 19 | $2,523 | $467.77 | 18.5% |
| 84270 | Sex hormone binding globulin (protein) level | Office | 2023 | 11 | 19 | $1,390 | $390.31 | 28.1% |
| 82533 | Cortisol (hormone) measurement, total | Office | 2023 | 15 | 24 | $2,092 | $383.28 | 18.3% |
| 84146 | Prolactin (milk producing hormone) level | Office | 2023 | 14 | 19 | $1,939 | $360.81 | 18.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 21 | 24 | $2,073 | $313.00 | 15.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 19 | $1,053 | $196.84 | 18.7% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 14 | 15 | $706.89 | $93.19 | 13.2% |
About Dr. Amit Vora, MD
Dr. Amit Vora, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Knoxville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1982745808.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amit Vora, MD has received a total of $728,648 in payments from pharmaceutical and medical device companies, with $74,885 received in 2024. These payments were reported across 1,584 transactions from 52 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($626,115).
As a Medicare-enrolled provider, Vora has provided services to 7,519 Medicare beneficiaries, totaling 11,003 services with total Medicare billing of $316,641. Data is available for 4 years (2020–2023), covering 106 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Knoxville, TN
- Active Since 02/12/2007
- Last Updated 06/18/2025
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1982745808
Products in Payments
- MOUNJARO (Drug) $137,666
- JARDIANCE (Drug) $112,181
- Ozempic (Drug) $106,295
- RYBELSUS (Drug) $77,718
- Tresiba (Drug) $73,472
- Victoza (Drug) $40,467
- DEXCOM G7 GSS (161) (Medical Supply) $18,115
- Kerendia (Drug) $17,421
- AFREZZA (Drug) $16,694
- FREESTYLE LIBRE 3 (Device) $15,979
- Xultophy 100/3.6 (Drug) $14,860
- Rybelsus (Drug) $14,840
- INVOKANA (Drug) $7,601
- DEXCOM G6 TRANSMITTER (Device) $6,258
- Omnipod (Device) $5,531
- DEXCOM G6 CGM SYSTEM (Device) $4,731
- t:slim X2 insulin pump (Device) $3,843
- GVOKE HYPOPEN (Drug) $3,607
- Dexcom CGM (Device) $3,344
- t-slim insulin pump (Device) $2,681
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Knoxville
Casey Page, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $165,638
Endocrinology, Diabetes & Metabolism $165,638
Dr. David Irizarry, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $89,566
Endocrinology, Diabetes & Metabolism $89,566
Mubashir Mahmood, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $50,171
Endocrinology, Diabetes & Metabolism $50,171
Thomas Doty, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $23,541
Endocrinology, Diabetes & Metabolism $23,541
Daniel Mccammon, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $9,890
Endocrinology, Diabetes & Metabolism $9,890
Gregory Moffitt, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $5,924
Endocrinology, Diabetes & Metabolism $5,924